Effects of combined therapies on the survival of pleural mesothelioma patients treated in Brescia, 1982-2006

Tumori

Volumn 98, Issue 2, 2012, Pages 215-219

  Barbieri, Pietro Gino ^a   Marinaccio, Alessandro ^b   Ferrante, Pierpaolo ^b   Scarselli, Alberto ^b   Pinelli, Valentina ^c   Tassi, Gianfranco ^c  

^a Local Public Health Authority   (Italy)

^b Workers' Compensation Authority (INAIL)   (Italy)

^c Brescia General Hospital   (Italy)

Author keywords

Pleural malignant mesothelioma; Survival; Therapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CANCER MORTALITY; CANCER PALLIATIVE THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ASSESSMENT; CONTROLLED STUDY; DECORTICATION; FEMALE; FOLLOW UP; HUMAN; ITALY; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; OUTCOME ASSESSMENT; PLEURA MESOTHELIOMA; PLEURECTOMY; RISK ASSESSMENT; SEX DIFFERENCE; SURVIVAL RATE; SURVIVAL TIME; TREATMENT PLANNING; TREND STUDY; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; IMMUNOTHERAPY; KAPLAN MEIER METHOD; MESOTHELIOMA; METHODOLOGY; MIDDLE AGED; MORTALITY; MULTIVARIATE ANALYSIS; PALLIATIVE THERAPY; PLEURA TUMOR; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK FACTOR;

AGED; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; HUMANS; IMMUNOTHERAPY; ITALY; KAPLAN-MEIER ESTIMATE; MALE; MESOTHELIOMA; MIDDLE AGED; MULTIVARIATE ANALYSIS; PALLIATIVE CARE; PLEURAL NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 84864881205     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161209800206     Document Type: Article

References (27)

1. Peto J, Hodgson JT, Matthews FE, Jones JR: Continuing increase in mesothelioma mortality in Britain. Lancet, 345:535-539, 1995.
2. Ilg AG, Bignon J, Valleron AJ: Estimation of the past and future burden of mortality from mesothelioma in France. Occup Environ Med, 55: 760-765, 1998. (Pubitemid 28480318)
3. Merler E, Lagazio C, Biggeri A: Trends in mortality from primary pleural tumour and incidence of pleural mesothelioma in Italy: a particular serious situation. Epidemiol Prev, 23: 316-326, 1999.
4. Pelucchi C, Malvezzi M, La Vecchia C, Levi F, Decarli A, Negri E: The mesothelioma epidemic in Western Europe: an update. Br J Cancer, 90: 1022-1024, 2004. (Pubitemid 38495822)
5. Marinaccio A, Montanaro F, Mastrantonio M, Uccelli R, Altavista P, Nesti M, Costantini AS, Gorini G: Predictions of mortality from pleural mesothelioma in Italy: a model based on asbestos consumption figures supports results from age-period-cohort models. Int J Cancer, 115: 142-147, 2005. (Pubitemid 40559680)
6. Marinaccio A, Binazzi A, Di Marzio D, Scarselli A, Verardo M, Mirabelli D, Gennaro V, Mensi C, Merler E, De Zotti R, Romanelli A, Chellini E, Silvestri S, Pascucci C, Forastiere F, Menegozzo M, Musti M, Cauzillo G, Nicita C, Melis M, Iavicoli S e gruppo di lavoro ReNaM (eds). Registro Nazionale dei Mesoteliomi. Terzo Rapporto. Istituto Superiore per la Prevenzione e la Sicurezza del Lavoro (ISPESL), Roma, 2010.
7. Magnani C, Viscomi S, Dalmasso P, Ivaldi C, Mirabelli D, Terracini B: Survival after malignant mesothelioma. A population-base study in Italy. Tumori, 88: 266-269, 2002.
8. Marinaccio A, Nesti M & Regional Operational Centers: Survival analysis for mesothelioma cases in the Italian register (Re Na M). Eur J Cancer, 39: 1290-1295, 2003.
9. Gorini G, De Gregorio G, Silvestri S, Chellini E, Cupelli V, Seniori Costantini A: Survival of malignant pleural mesothelioma cases in the Tuscan mesothelioma register, 1988-2000: a population-based study. Eur J Cancer Prev, 14: 195-199, 2005. (Pubitemid 40780441)
10. Montanaro F, Rosato R, Gangemi M, Roberti S, Ricceri F, Merler E, Gennaro V, Romanelli A, Chellini E, Pascucci C, Musti M, Nicita C, Barbieri PG, Marinaccio A, Magnani C, Mirabelli D: Survival of pleural malignant mesothelioma in Italy: a population-based study. Int J Cancer, 124: 201-207, 2009.
11. Nakano T, Miyake M, Takenaka M, Iwahashi N, Hada T, Higashino K: A pilot Phase II study of cisplatin, doxorubicin, and vindesine for the treatment of malignant pleural mesothelioma. Eur Respir Rev, 3: 211-212, 1993. (Pubitemid 23135376)
12. Boutin C, Nussbaum E, Monnet I, Bignon J, Vanderschueren R, Guerin JC, Menard O, Mignot P, Dabouis G, Douillard JY: Intrapleural treatment with recombinant gamma interferon in early stage malignant pleural mesothelioma. Cancer, 74: 2460-2467, 1994. (Pubitemid 24320849)
13. Ong ST, Vogelzang NJ: Chemotherapy in malignant pleural mesothelioma. A review. J Clin Oncol, 14: 107-117, 1996.
14. Sterman DH, Kaiser LR, Albelda SM: Advances in the treatment of malignant pleural mesothelioma. Chest, 116: 504-520, 1999. (Pubitemid 29382138)
15. Procopio A, Strizzi L, Giuffrida A, Scarpa S, Giuliano M, Iezzi T, Mutti L, Modesti A: Human malignant mesothelioma of the pleura: new perspectives for diagnosis and therapy. Arch Chest Dis, 53: 241-243, 1998. (Pubitemid 28383198)
16. Sugarbaker DJ, Norberto JJ: Multimodality management of malignant pleural mesothelioma. Chest, 113 (Suppl 1):615-655, 1998.
17. Zellos LS, Sugarbaker DJ: Multimodality treatment of diffuse malignant pleural mesothelioma. Semin Oncol, 29:41-50, 2002. (Pubitemid 34163534)
18. Barbieri PG, Marinaccio A, Festa R, Nesti M, Marchetti G, Trigiani M, Tassi GF: Analisi della sopravvivenza dei mesoteliomi maligni trattati a Brescia dal 1982 al 2000. Epidemiol Prev, 28:107-113, 2004.
19. Nesti M, Adamoli S, Ammirabile F, Ascoli V, Barbieri PG, Cacciarini V, Candela S, Cavone D, Cauzillo G, Chellini E, Chiappino G, Convertini L, Crosignani P, Gennaro V, Gioffrè F, Gorini G, Iavicoli S, Magnani C, Mangone L, Marinaccio A, Marras T, Menegozzo M, Mensi C, Merler E, Mirabelli D, Musti M, Montanaro F, Mosciatti P, Nicita C, Pannelli F, Pascucci C, Pezzarossi AM, Romanelli A, Scarselli A, Scondotto S, Silvestri S, Storchi C, Tosi S, Tumino S: Linee guida per la rilevazione e la definizione dei casi di mesotelioma maligno e la trasmissione delle informazioni all'ISPESL da parte dei Centri Operativi Regionali. Istituto Superiore per la Prevenzione e la Sicurezza del Lavoro (ISPESL), Roma, 2004.
20. Galateau-Sallè F, Vignaud JM, Burke L, Gibbs A, Brambilla E, Attanoos R, Goldberg M, Launoy G & Mesopath group: Well-differentiated papillary mesothelioma of the pleura: a series of 24 cases. Am J Surg Pathol, 28: 534-540, 2004.
21. Kaplan EL, Meier P: Non parametric estimation from incomplete observations. J Am Stat Assoc, 53: 457-481, 1958.
22. Cox D: Regression models and life-tables. J R Soc Stat, 34:187-220, 1972.
23. Curran D, Sahmoud T, Therasse P, Van Meerbeek J, Postmus PE, Giaccone G: Prognostic factors in patient with pleural mesothelioma: the European Organisation for Research and Treatment of Cancer Experience. J Clin Oncol, 16: 145-152, 1998. (Pubitemid 28041592)
24. Herndon JE, Green MR, Chahinian AP, Corson JM, Suzuki Y, Vogelzang NJ: Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the cancer and leukemia Group B. Chest, 113: 723-731, 1998. (Pubitemid 28130949)
25. De Pangher Manzini V, Brollo A, Franceschi S, De Matthaeis M, Talamini R, Bianchi C: Prognostic factors of malignant mesothelioma of the pleura. Cancer, 72: 410-417, 1993. (Pubitemid 23193446)
26. Pinto C, Ardizzoni A, Betta PG, Facciolo F, Tassi G, Tonoli S, Zompatori M, Alessandrini G, Magrini SM, Tiseo M, Mutri V: Expert opinions of the first Italian consensus conference on the management of the malignant pleural mesothelioma. Am J Clin Oncol, 34: 99-109, 2011.
27. Scherpereel A, Astoul P, Baas P, Berghmans T, Clayson H, de Vuyst P, Dienemann H, Galateau-Sallè F, Hennequin C, Hillerdal G, Le Péchoux C, Mutti L, Pairon JC, Stahel R, van Houtte P, van Meerbeeck J, Waller D, Weder W: Guidelines of the European Respiratory Society and the European Society of Thoracic Surgeon for management of malignant pleural mesothelioma. Eur Respir J, 35: 479-495, 2010.